Ledger.Open graph →
SEC Form D · filed March 4, 2021

Spotlight Therapeutics, Inc

Offering
$16.0M
Sold
$15.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Hayward, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Mary Haak-Frendscho · Hayward, CAExec · DirectorJacob Corn · Hayward, CADirectorPatrick D. Hsu · Hayward, CADirectorAlexander D. Marson · Hayward, CADirectorBlake Byers · SAN FRANCISCO, CADirectorEcho Street Capital Advisors LLC · New York, NYDirectorBrian Mark · Fort Lauderdale, FLDirectorScott Auker · Fort Lauderdale, FLDirectorAnthony Perera · Plantation, FLExec · DirectorSunCap Fund Manager, LLC · Fort Lauderdale, FLDirectorBrian P. Mcmanamon · Westlake, OHExec · DirectorRobert C. Mcmanamon · Westlake, OHDirectorYvon J. Roy · Montreal, Quebec, CanadaDirectorMichael Salzhauer · New York, NYDirectorMichael D. Schmalzbach · Miami Beach, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗